Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “overweight” rating reissued by equities researchers at J P Morgan Chase & Co in a research report issued to clients and investors on Friday, The Fly reports. They currently have a $1,050.00 target price on the medical equipment provider’s stock. J P Morgan Chase & Co’s price target would suggest a potential upside of 8.05% from the stock’s current price.

Several other analysts have also weighed in on the company. Canaccord Genuity restated a “buy” rating and issued a $800.00 price objective on shares of Intuitive Surgical in a report on Friday, March 24th. Morgan Stanley set a $950.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a report on Monday, May 22nd. Royal Bank Of Canada upped their price objective on Intuitive Surgical from $720.00 to $770.00 and gave the company a “sector perform” rating in a report on Monday, April 17th. Barclays PLC restated a “buy” rating and issued a $800.00 price objective on shares of Intuitive Surgical in a report on Sunday, March 26th. Finally, Leerink Swann restated an “outperform” rating and issued a $850.00 price objective (up previously from $840.00) on shares of Intuitive Surgical in a report on Saturday, April 22nd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $917.64.

Intuitive Surgical (NASDAQ:ISRG) opened at 971.73 on Friday. The stock has a market cap of $35.80 billion, a PE ratio of 48.99 and a beta of 0.39. The stock has a 50 day moving average price of $934.93 and a 200-day moving average price of $803.42. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $974.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a return on equity of 15.41% and a net margin of 27.99%. The company’s revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.62 earnings per share. On average, analysts expect that Intuitive Surgical will post $23.59 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/07/21/intuitive-surgical-inc-nasdaqisrg-given-overweight-rating-at-j-p-morgan-chase-co.html.

In related news, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the transaction, the senior vice president now directly owns 3,046 shares of the company’s stock, valued at $2,702,076.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Marshall Mohr sold 8,950 shares of the company’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $835.89, for a total value of $7,481,215.50. Following the transaction, the chief financial officer now directly owns 6,422 shares in the company, valued at $5,368,085.58. The disclosure for this sale can be found here. Insiders have sold 28,041 shares of company stock worth $24,493,708 over the last three months. 2.50% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP raised its position in Intuitive Surgical by 2.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 63,956 shares of the medical equipment provider’s stock valued at $40,561,000 after buying an additional 1,480 shares during the last quarter. Thrivent Financial for Lutherans raised its position in Intuitive Surgical by 7.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,360 shares of the medical equipment provider’s stock valued at $862,000 after buying an additional 100 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in Intuitive Surgical by 19.8% in the fourth quarter. UBS Asset Management Americas Inc. now owns 105,606 shares of the medical equipment provider’s stock valued at $66,974,000 after buying an additional 17,479 shares during the last quarter. Perigon Wealth Management LLC raised its position in Intuitive Surgical by 5.9% in the fourth quarter. Perigon Wealth Management LLC now owns 2,255 shares of the medical equipment provider’s stock valued at $1,680,000 after buying an additional 125 shares during the last quarter. Finally, Kentucky Retirement Systems acquired a new position in Intuitive Surgical during the fourth quarter valued at $1,783,000. 97.53% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

The Fly

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.